找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊DRUG DISCOVERY TODAY 2024/2025影响因子:6.566 (DRUG DISCOV TODAY) (1359-6446). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:20665; 2023 JIF:6.566; JIFRank: 23/354 ; Rank-JIF: 23; Number-of-JIF:354; 5 Year JIF:7.382; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.3; Immediacy Index:1.6; Immediacy Index-dealt:1.692; 2023 JCI:1.05; JCI Rank: 76/354 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:78.67; Eigenfactor:0.016; Normalized Eigenfactor:3.481; Article Influence Score:1.52; JIF Percentile:93.6; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:239; % of Articles in Citable items:0; Cited Half-Life:6.5; Citing Half-Life:5.5; % of OA Gold:0.2512; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRIDGE,
投票 SCIE期刊JOURNAL OF PSYCHOPHARMACOLOGY 2024/2025影响因子:4.54 (J PSYCHOPHARMACOL) (0269-8811). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:8630; 2023 JIF:4.54; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:4.552; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:1; Immediacy Index-dealt:1.106; 2023 JCI:1.28; JCI Rank: 44/354 ; Total Articles:84; JCI Quartile:Q1; JCI Percentile:81.13; Eigenfactor:0.008; Normalized Eigenfactor:0.458; Article Influence Score:0.66; JIF Percentile:77.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:104; % of Articles in Citable items:0.8077; Cited Half-Life:7.8; Citing Half-Life:8.9; % of OA Gold:0.3934; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊Contemporary Clinical Trials 2024/2025影响因子:2.119 (CONTEMP CLIN TRIALS) (1551-7144). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:5356; 2023 JIF:2.119; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.152; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2; Immediacy Index:0.3; Immediacy Index-dealt:0.308; 2023 JCI:0.57; JCI Rank: 210/354 ; Total Articles:242; JCI Quartile:Q3; JCI Percentile:40.82; Eigenfactor:0.009; Normalized Eigenfactor:1.953; Article Influence Score:0.921; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q1; Citable Items:242; % of Articles in Citable items:1; Cited Half-Life:6.7; Citing Half-Life:8.9; % of OA Gold:0.3259; Publisher name:UNIV TORONTO PRESS INC; Publisher address:JOURNALS DIVISION, 5201 DUFFERIN ST, D
投票 SCIE期刊Pharmacogenomics & Personalized Medicine 2024/2025影响因子:1.859 (PHARMACOGEN PERS MED) (NULL). (PHARMACOLOGY & PHARM  ...234
Total Citations:984; 2023 JIF:1.859; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.924; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.494; 2023 JCI:0.56; JCI Rank: 215/354 ; Total Articles:80; JCI Quartile:Q3; JCI Percentile:39.41; Eigenfactor:0.001; Normalized Eigenfactor:0.291; Article Influence Score:0.448; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:93; % of Articles in Citable items:0.8602; Cited Half-Life:3.3; Citing Half-Life:6.4; % of OA Gold:0.9846; Publisher name:MICROBIOL RES FOUNDATION; Publisher address:JAPAN ACAD SOC CENTER BLDG 4-16
投票 SCIE期刊Journal of Global Antimicrobial Resistance 2024/2025影响因子:3.719 (J GLOB ANTIMICROB RE) (2213-7165). (PHARMACOLOGY  ...234
Total Citations:5239; 2023 JIF:3.719; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:3.877; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.6; Immediacy Index-dealt:0.604; 2023 JCI:0.91; JCI Rank: 98/354 ; Total Articles:159; JCI Quartile:Q2; JCI Percentile:72.46; Eigenfactor:0.008; Normalized Eigenfactor:1.765; Article Influence Score:0.861; JIF Percentile:74.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:170; % of Articles in Citable items:0.9353; Cited Half-Life:3.6; Citing Half-Life:6; % of OA Gold:0.9088; Publisher name:IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC; Publisher address:445 HOES LAN
投票 SCIE期刊INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS 2024/2025影响因子:1.444 (INT J MED MUSHROOMS) (1521-9437). (PHARMACOLOGY  ...234
Total Citations:1887; 2023 JIF:1.444; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.582; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.4; Immediacy Index-dealt:0.448; 2023 JCI:0.33; JCI Rank: 288/354 ; Total Articles:71; JCI Quartile:Q4; JCI Percentile:18.79; Eigenfactor:0.001; Normalized Eigenfactor:0.182; Article Influence Score:0.204; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:83; % of Articles in Citable items:0.8554; Cited Half-Life:7.3; Citing Half-Life:7.4; % of OA Gold:0.0075; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA
投票 SCIE期刊International Immunopharmacology 2024/2025影响因子:4.814 (INT IMMUNOPHARMACOL) (1567-5769). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:33221; 2023 JIF:4.814; JIFRank: 50/354 ; Rank-JIF: 50; Number-of-JIF:354; 5 Year JIF:5.188; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.6; Immediacy Index:0.9; Immediacy Index-dealt:0.915; 2023 JCI:1.24; JCI Rank: 52/354 ; Total Articles:1426; JCI Quartile:Q1; JCI Percentile:85.45; Eigenfactor:0.033; Normalized Eigenfactor:7.248; Article Influence Score:0.925; JIF Percentile:86; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:1554; % of Articles in Citable items:0.9176; Cited Half-Life:3.9; Citing Half-Life:5.8; % of OA Gold:0.1448; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23
投票 SCIE期刊MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2024/2025影响因子:1.45 (MED LETT DRUGS THER) (0025-732X). (PHARMACOLOGY & PH  ...234
Total Citations:449; 2023 JIF:1.45; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.172; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:1.3; Immediacy Index-dealt:1.339; 2023 JCI:0.28; JCI Rank: 298/354 ; Total Articles:54; JCI Quartile:Q4; JCI Percentile:15.96; Eigenfactor:0; Normalized Eigenfactor:0.003; Article Influence Score:0.022; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:54; % of Articles in Citable items:1; Cited Half-Life:3.1; Citing Half-Life:3.2; % of OA Gold:0; Publisher name:NULL; Publisher address:NULL;
投票 SCIE期刊ADVANCED DRUG DELIVERY REVIEWS 2024/2025影响因子:15.248 (ADV DRUG DELIVER REV) (0169-409X). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:47365; 2023 JIF:15.248; JIFRank: 4/354 ; Rank-JIF: 4; Number-of-JIF:354; 5 Year JIF:17.699; 5 Year JIF Quartile:Q1; JIF Without Self Cites:14.6; Immediacy Index:3.6; Immediacy Index-dealt:3.624; 2023 JCI:2.33; JCI Rank: 7/354 ; Total Articles:1; JCI Quartile:Q1; JCI Percentile:98.16; Eigenfactor:0.028; Normalized Eigenfactor:6.031; Article Influence Score:3.274; JIF Percentile:99; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:174; % of Articles in Citable items:0.0057; Cited Half-Life:7.7; Citing Half-Life:6.3; % of OA Gold:0.3154; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01-811;
投票 SCIE期刊BIOMEDICAL CHROMATOGRAPHY 2024/2025影响因子:1.838 (BIOMED CHROMATOGR) (0269-3879). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:5273; 2023 JIF:1.838; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.829; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.5; Immediacy Index-dealt:0.527; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:228; JCI Quartile:Q4; JCI Percentile:20.93; Eigenfactor:0.003; Normalized Eigenfactor:0.672; Article Influence Score:0.274; JIF Percentile:17.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:235; % of Articles in Citable items:0.9702; Cited Half-Life:6.4; Citing Half-Life:6.3; % of OA Gold:0.0331; Publisher name:NULL; Publisher address:NULL;
投票 SCIE期刊Infection and Drug Resistance 2024/2025影响因子:2.928 (INFECT DRUG RESIST) (1178-6973). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:9759; 2023 JIF:2.928; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.657; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.6; Immediacy Index-dealt:0.614; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:601; JCI Quartile:Q2; JCI Percentile:61.72; Eigenfactor:0.014; Normalized Eigenfactor:3.159; Article Influence Score:0.752; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:682; % of Articles in Citable items:0.8812; Cited Half-Life:3.4; Citing Half-Life:5.5; % of OA Gold:0.9864; Publisher name:UNIV WESTERN AUSTRALIA, DEPT EUROPEAN LANGUAGES & STUDIES; Publisher addr
投票 SCIE期刊JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2024/2025影响因子:3.987 (J ANTIMICROB CHEMOTH) (0305-7453). (PHARMACOLOGY & PHA  ...234
Total Citations:33199; 2023 JIF:3.987; JIFRank: 85/354 ; Rank-JIF: 85; Number-of-JIF:354; 5 Year JIF:4.647; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.6; Immediacy Index:0.9; Immediacy Index-dealt:0.915; 2023 JCI:1.11; JCI Rank: 67/354 ; Total Articles:336; JCI Quartile:Q1; JCI Percentile:79.81; Eigenfactor:0.026; Normalized Eigenfactor:5.768; Article Influence Score:1.324; JIF Percentile:65.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:364; % of Articles in Citable items:0.9231; Cited Half-Life:8.8; Citing Half-Life:6.1; % of OA Gold:0.2982; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILADE
投票 SCIE期刊ACTA POLONIAE PHARMACEUTICA 2024/2025影响因子:0.454 (ACTA POL PHARM) (0001-6837). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:1879; 2023 JIF:0.454; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.481; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.195; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:73; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.054; Article Influence Score:0.056; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:88; % of Articles in Citable items:0.8295; Cited Half-Life:12.1; Citing Half-Life:7.1; % of OA Gold:0.883; Publisher name:GEOGRAFSKI INST ANTONA MELIKA ZRC SAZU; Publisher address:GOSPOSKA ULICA 13, LJUB
投票 SCIE期刊CHEMOTHERAPY 2024/2025影响因子:2.116 (CHEMOTHERAPY) (0009-3157). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation In  ...234
Total Citations:1554; 2023 JIF:2.116; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.101; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2; Immediacy Index:<0.1; Immediacy Index-dealt:0.035; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:22; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.001; Normalized Eigenfactor:0.127; Article Influence Score:0.414; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:29; % of Articles in Citable items:0.7586; Cited Half-Life:13.9; Citing Half-Life:7; % of OA Gold:0.17; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊CLINICAL NEUROPHARMACOLOGY 2024/2025影响因子:0.816 (CLIN NEUROPHARMACOL) (0362-5664). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:1911; 2023 JIF:0.816; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:1.137; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.3; Immediacy Index-dealt:0.326; 2023 JCI:0.17; JCI Rank: 324/354 ; Total Articles:2; JCI Quartile:Q4; JCI Percentile:8.62; Eigenfactor:0.001; Normalized Eigenfactor:0.144; Article Influence Score:0.317; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:43; % of Articles in Citable items:0.0465; Cited Half-Life:13.7; Citing Half-Life:9; % of OA Gold:0.0822; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN
投票 SCIE期刊FOOD AND DRUG LAW JOURNAL 2024/2025影响因子:0.378 (FOOD DRUG LAW J) (1064-590X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sci  ...234
Total Citations:182; 2023 JIF:0.378; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.303; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.054; 2023 JCI:0.1; JCI Rank: 341/354 ; Total Articles:14; JCI Quartile:Q4; JCI Percentile:15.32; Eigenfactor:0; Normalized Eigenfactor:0.022; Article Influence Score:0.125; JIF Percentile:36.7; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:15; % of Articles in Citable items:0.9333; Cited Half-Life:13.2; Citing Half-Life:9.6; % of OA Gold:0; Publisher name:BENTHAM SCIENCE PUBL LTD; Publisher address:EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZON
投票 SCIE期刊PHARMACOLOGY & THERAPEUTICS 2024/2025影响因子:12.151 (PHARMACOL THERAPEUT) (0163-7258). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:23307; 2023 JIF:12.151; JIFRank: 8/354 ; Rank-JIF: 8; Number-of-JIF:354; 5 Year JIF:12.567; 5 Year JIF Quartile:Q1; JIF Without Self Cites:11.9; Immediacy Index:1.9; Immediacy Index-dealt:1.937; 2023 JCI:1.93; JCI Rank: 16/354 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:95.62; Eigenfactor:0.02; Normalized Eigenfactor:4.431; Article Influence Score:2.919; JIF Percentile:97.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:147; % of Articles in Citable items:0; Cited Half-Life:6.6; Citing Half-Life:7.9; % of OA Gold:0.2694; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 2024/2025影响因子:2.161 (AM J HEALTH-SYST PH) (1079-2082). (PHARMACOLOGY &  ...234
Total Citations:6317; 2023 JIF:2.161; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.623; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.433; 2023 JCI:0.49; JCI Rank: 243/354 ; Total Articles:148; JCI Quartile:Q3; JCI Percentile:31.5; Eigenfactor:0.006; Normalized Eigenfactor:1.221; Article Influence Score:0.703; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:170; % of Articles in Citable items:0.8706; Cited Half-Life:8.1; Citing Half-Life:6.7; % of OA Gold:0.1097; Publisher name:INT SOC AGING & DISEASE; Publisher address:EDITORIAL OFF, 3400 CAMP BOWIE
投票 SCIE期刊SKIN PHARMACOLOGY AND PHYSIOLOGY 2024/2025影响因子:2.846 (SKIN PHARMACOL PHYS) (1660-5527). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:2310; 2023 JIF:2.846; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:3.667; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.5; Immediacy Index-dealt:0.546; 2023 JCI:0.9; JCI Rank: 101/354 ; Total Articles:15; JCI Quartile:Q2; JCI Percentile:71.61; Eigenfactor:0.001; Normalized Eigenfactor:0.241; Article Influence Score:0.728; JIF Percentile:55.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:18; % of Articles in Citable items:0.8333; Cited Half-Life:10.6; Citing Half-Life:8.9; % of OA Gold:0.2604; Publisher name:MOSBY-ELSEVIER; Publisher address:360 PARK AVENUE SOUTH, NEW YORK, USA, NY,
投票 SCIE期刊Therapeutic Innovation & Regulatory Science 2024/2025影响因子:2.187 (THER INNOV REGUL SCI) (2168-4790). (PHARMACOLOGY  ...234
Total Citations:1381; 2023 JIF:2.187; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:1.622; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.208; 2023 JCI:0.38; JCI Rank: 276/354 ; Total Articles:77; JCI Quartile:Q4; JCI Percentile:22.18; Eigenfactor:0.003; Normalized Eigenfactor:0.628; Article Influence Score:0.556; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:104; % of Articles in Citable items:0.7404; Cited Half-Life:3.7; Citing Half-Life:7.5; % of OA Gold:0.4268; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 07:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块